Research programme: infectious disease vaccines - OPKO Health/CIATEJ

Drug Profile

Research programme: infectious disease vaccines - OPKO Health/CIATEJ

Alternative Names: Dengue fever vaccine - OPKO Health/CIATEJ; Influenza vaccine - OPKO Health/CIATEJ; West Nile virus vaccine - OPKO Healt/CIATEJ

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator CIATEJ; OPKO Health
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Dengue; Influenza virus infections; West Nile virus infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for research development in West Nile virus infections in Mexico (Parenteral)
  • 16 Jul 2016 No recent reports of development identified for research development in Dengue in Mexico (Parenteral)
  • 16 Jul 2016 No recent reports of development identified for research development in Influenza-virus-infections in Mexico (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top